Literature DB >> 686544

Elevated urinary prostaglandins and the effects of aspirin on renal function in lupus erythematosus.

R P Kimberly, J R Gill, R E Bowden, H R Keiser, P H Plotz.   

Abstract

We studied the urinary excretion of immunoreactive prostaglandin E-like material (iPGE) and renal function in seven women with systemic lupus erythematosus to evaluate the relation between urinary iPGE and the increase in serum creatinine in patients taking aspirin. The mean pretreatment excretion of urinary iPGE in patients with lupus erythematosus, 42.7 +/- 6.4 ng/h, was significantly higher than the value of 29.0 +/- 1.9 ng/h for normal subjects (P less than 0.02). With aspirin, the urinary iPGE decreased an average of 45% (P less than 0.001). Increases in serum creatinine and blood urea nitrogen confirmed our previous clinical observations. The concomitant mean fall in creatinine clearance of 18% (P less than 0.001) was accompanied by a 14% decrease in inulin clearance (P less than 0.005); p-aminohippurate clearance fell 29% (P less than 0.005). The decline in urinary iPGE preceded the fall in creatinine clearance but was significantly correlated with it (r = 0.78; P less than 0.001). The observed changes reversed rapidly when aspirin was stopped. These data show that, in these patients with high urinary iPGE excretion, aspirin causes significant changes in renal function that may be mediated by the inhibition of prostaglandin synthesis.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 686544     DOI: 10.7326/0003-4819-89-3-336

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  18 in total

1.  Renal haemodynamic characteristics in patients with lupus nephritis.

Authors:  M Nakano; M Ueno; H Hasegawa; T Watanabe; T Kuroda; S Ito; M Arakawa
Journal:  Ann Rheum Dis       Date:  1998-04       Impact factor: 19.103

2.  A prospective study of renal disease in patients with early rheumatoid arthritis.

Authors:  Y Koseki; C Terai; M Moriguchi; M Uesato; N Kamatani
Journal:  Ann Rheum Dis       Date:  2001-04       Impact factor: 19.103

Review 3.  The beneficial role of vitamin D in systemic lupus erythematosus (SLE).

Authors:  Khanh vinh quốc Luong; Lan Thi Hoàng Nguyễn
Journal:  Clin Rheumatol       Date:  2012-07-17       Impact factor: 2.980

4.  [Secondary gout and pseudo-Bartter syndrome in females with laxative abuse].

Authors:  O Adam; F D Goebel
Journal:  Klin Wochenschr       Date:  1987-09-01

Review 5.  The treatment of lupus nephritis.

Authors:  J S Cameron
Journal:  Pediatr Nephrol       Date:  1989-07       Impact factor: 3.714

6.  Reversal by prostaglandin E2 infusion of the effects of indomethacin on the excretion of nitrogenous compounds in the rat.

Authors:  D J Rowe; G Gedeon
Journal:  Br J Exp Pathol       Date:  1983-06

7.  Formation and action of prostaglandins in the kidney.

Authors:  P C Weber; B Scherer; W Siess; E Held; J Schnermann
Journal:  Klin Wochenschr       Date:  1979-10-01

8.  Effect of acetylsalicylic acid on renal function in systemic lupus erythematosus.

Authors:  S Rasmussen; J Petersen; I L Nielsen; P Christensen; T Hilden
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

9.  Effects of indomethacin on kidney function in type 1 (insulin-dependent) diabetic patients with nephropathy.

Authors:  E Hommel; E Mathiesen; S Arnold-Larsen; B Edsberg; U B Olsen; H H Parving
Journal:  Diabetologia       Date:  1987-02       Impact factor: 10.122

10.  Functional significance of renal prostacyclin and thromboxane A2 production in patients with systemic lupus erythematosus.

Authors:  C Patrono; G Ciabattoni; G Remuzzi; E Gotti; S Bombardieri; O Di Munno; G Tartarelli; G A Cinotti; B M Simonetti; A Pierucci
Journal:  J Clin Invest       Date:  1985-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.